90 T (Brilinta 90 mg)
Generic Name: ticagrelor
This pill with imprint "90 T" is Yellow, Round and has been identified as Brilinta 90 mg. It is supplied by AstraZeneca.
Brilinta is used in the treatment of acute coronary syndrome; prevention of atherothrombotic events and belongs to the drug class platelet aggregation inhibitors. Risk cannot be ruled out during pregnancy. Brilinta 90 mg is not a controlled substance under the Controlled Substance Act (CSA).
Brilinta
- Generic Name:
- ticagrelor
- Imprint:
- 90 T
- Strength:
- 90 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- AstraZeneca
- National Drug Code (NDC):
- 00186-0777
More about Brilinta (ticagrelor)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 22 Reviews – Add your own review/rating
- Drug class: platelet aggregation inhibitors
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
